Well, the debate was held between Vice President Kamala Harris and former President Donald Trump, and healthcare, particularly the Affordable Care Act (ACA), emerged as a key issue during the final stages of the discussion. Moderated by journalists Linsey Davis and David Muir, the debate highlighted the contrasting views on the potential future of the ACA.
Former President Trump, when pressed by Ms. Davis, remained vague about his intentions regarding the ACA. While Trump confirmed that he still envisioned replacing the ACA, his response lacked specifics. He mentioned having “concepts of a plan,” but stopped short of offering detailed proposals. His remarks hinted at potential changes to the law, but only if those changes could offer a “better and less expensive” solution. He further noted that the public would hear more about these concepts in the “not-too-distant future.”
This ambiguity reflects a broader shift within the Republican Party, which, under Trump’s leadership, had long campaigned to repeal the ACA. The former president made several attempts to dismantle the law during his first term, but those efforts failed to gain enough support in Congress, leaving the ACA intact. However, the healthcare debate resurfaced in the 2024 campaign, as Trump took to his social-media platform, Truth Social, to underscore healthcare as a priority issue, renewing his promise to replace the ACA if re-elected.
Vice President Harris took the opportunity during the debate to defend and promote the ACA. She pointed to the Biden Administration’s track record in preserving the healthcare law and expanding its reach. Harris underscored the ACA’s protections for individuals with pre-existing conditions and its pivotal role in reducing the uninsured rate.
Harris also highlighted the success of the American Rescue Plan Act (ARPA) of 2021, which temporarily enhanced subsidies for individuals purchasing health coverage through ACA marketplaces. The ARPA subsidies significantly reduced healthcare costs for millions of Americans, making coverage more affordable during the COVID-19 pandemic. These subsidies are currently set to expire at the end of 2025, but Harris reiterated her administration’s commitment to continuing the ACA’s expansion and possibly extending these benefits.
Harris pointed to newly released data that underscores the ACA’s impact on Americans’ healthcare access. According to the Biden Administration, 1 in 7 U.S. residents have gained coverage through the ACA marketplaces since 2014.
The ACA has seen a notable shift in public opinion since its inception. In November 2016, around the time of Trump’s election, a Kaiser Family Foundation (KFF) tracking poll showed that only 43 percent of Americans held a favorable opinion of the law, while many were critical of the individual mandate and rising premium costs. However, as the ACA continued to provide tangible benefits to millions of people, public sentiment shifted. A more recent KFF survey conducted in April 2024 revealed that 62 percent of Americans now hold a favorable view of the ACA, compared to 37 percent who still view it unfavorably.
Healthcare has long been a contentious issue in U.S. politics, and the future of the ACA continues to be a central topic in national debates. Trump’s vague references to a new healthcare plan leave many questions unanswered, particularly regarding how his administration would handle key provisions of the ACA, such as protections for pre-existing conditions, Medicaid expansion, and insurance affordability.
Harris, on the other hand, aims to solidify her position as a defender of the ACA, emphasizing the need for stability in healthcare policy and continued efforts to expand coverage.
With millions of Americans covered under ACA marketplaces and new healthcare challenges on the horizon, the debate over the ACA’s future is far from settled. As the 2024 election unfolds, healthcare will undoubtedly remain a pivotal issue for voters, with both candidates offering vastly different paths forward.
EDITOR’S NOTE:
The opinions expressed in this article are solely those of the author and do not necessarily represent the views or opinions of MedLearn Media. We provide a platform for diverse perspectives, but the content and opinions expressed herein are the author’s own. MedLearn Media does not endorse or guarantee the accuracy of the information presented. Readers are encouraged to critically evaluate the content and conduct their own research. Any actions taken based on this article are at the reader’s own discretion.
The U.S. House of Representatives Budget Committee recently passed President Trump’s “big, beautiful bill,” aka a reconciliation bill, which is essentially a large spending package
Imagine the frustration if, after you enter into a separation agreement with a departing employee, whereby they promise to release all claims against you, you
Please log in to your account to comment on this article.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.
Fraud convictions don’t just punish a few bad claims; they can wipe out years of reimbursements. Don’t wait for an audit to learn the rules. Join Frank Cohen, MPA, for a live Q&A on spotting red flags, avoiding liability, and protecting your practice. Register now and bring your questions!
Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025. Register today and be a part of the conversation!
Copyright © 2025 RACmonitor. Powered by MedLearn Media.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
